Clinical Scorecard: The Role of lncRNA PVT1 in the Pathogenesis of Oral Squamous Cell Carcinoma
At a Glance
Category
Detail
Condition
Key Mechanisms
lncRNA PVT1 regulates oncogenic phenotypes including cell proliferation, invasion, immune evasion, chemoresistance, and is involved in m6A methylation and EMT.
Target Population
Care Setting
Key Highlights
lncRNA PVT1 is frequently overexpressed in OSCC and associated with poor prognosis, including details on m6A methylation and EMT.
Guideline-Based Recommendations
Diagnosis
Consider lncRNA PVT1 expression levels as a potential biomarker for OSCC diagnosis, supported by recent studies.
Management
Target lncRNA PVT1 in therapeutic strategies to improve treatment outcomes in OSCC, referencing clinical trials.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with diagnosed Oral Squamous Cell Carcinoma.
Incorporate strategies targeting lncRNA PVT1 to enhance therapeutic efficacy.
Clinical Best Practices
Utilize lncRNA PVT1 as a prognostic marker in clinical assessments, with examples of its application in patient stratification.
